RxDoctor Payments Data

Jennifer Romero

Family · Fort Morgan, CONPI 1295378016

Payments from drug & device makers

$740in general payments, 2019–2025

Across 41 payments — averaging $18.06 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$200
  • Biohaven Pharmaceutical Holding Company Ltd.$90
  • Lilly USA, LLC$88
  • Boehringer Ingelheim$82
  • Amarin Pharma, Inc.$32
  • Biodelivery Sciences International, Inc.$32
  • plus $217 from 10 others

What the payments were for

  • Food & beverage$740100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$740 in reported general payments places this provider in the 70th percentile of 2,182 family providers in Colorado.

See all family providers in Colorado

Medicare billing

Part B allowed, 2024
$37,338
Medicare patients
260
Services billed
625

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
NamzaricMemantine Hcl/Donepezil Hcl11$6,109
Albuterol Sulfate HfaAlbuterol Sulfate35$1,299
Ventolin HfaAlbuterol Sulfate12$832
Oxcarbazepine12$662
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav51$528
Methylprednisolone58$319
Levothyroxine Sodium57$316
Gabapentin19$264
Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst18$213
Benztropine Mesylate12$207
Cefdinir16$192
Azithromycin49$154
Tamsulosin Hcl19$150
Cephalexin23$127
Doxycycline Hyclate12$118

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AbbVieNamzaric$28$6,10911 claims
PfizerPaxlovid$15$011 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 2,182 family providers in Colorado.

Other family in Fort Morgan

See the full list for Colorado

Where these figures come from

Is this you, or does something look wrong? →